SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-008319
Filing Date
2017-03-21
Accepted
2017-03-21 19:07:27
Documents
2
Period of Report
2017-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2299
2 EX-24 DOCUMENT attachment1.htm EX-24 3948
  Complete submission text file 0000899243-17-008319.txt   7738
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Craig Adam R (Reporting) CIK: 0001339498 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-28386 | Film No.: 17705269